Alopecia Areata After Omalizumab Treatment for Chronic Spontaneous Urticaria

The document discussed a case of alopecia areata that developed after treatment with omalizumab for chronic spontaneous urticaria. The report highlighted a potential adverse dermatological effect of omalizumab, a monoclonal antibody commonly used to treat chronic spontaneous urticaria. The case underscored the need for clinicians to be aware of this possible side effect when prescribing omalizumab.